Get started
Author

Carole Dembek

Observed names: C Dembek, C. Dembek, C.J. Dembek, CAROLE DEMBEK, Carole J Dembek, Carole J. Dembek, Dembek, Carole
ORCID: 0000-0001-9748-6198
Observed ORCID: 0000-0001-9748-6198
OpenAlex ID: A5043925265
The Economic Burden of Schizophrenia in the United States
2022 · Aditi Kadakia, Maryaline Catillon, et al. · The Journal of Clinical Psychiatry · 240
PDF
Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis
2011 · Rachel Halpern, Agarwal, et al. · Patient Preference and Adherence · 110
PDF
Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies
2019 · Soojin Cho-Reyes, Bartolome R. Celli, et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 96
PDF
Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis
2021 · Aditi Kadakia, Carole Dembek, et al. · BMC Psychiatry · 84
PDF
Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis
2020 · Maryam Navaie, Carole Dembek, et al. · Chronic Respiratory Disease · 58
PDF
The economic and humanistic burden of bipolar disorder in adults in the United States
2023 · Carole Dembek, deMauri Mackie, et al. · Annals of General Psychiatry · 44
PDF
Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia
2021 · Aditi Kadakia, Qi Fan, et al. · Schizophrenia Research Cognition · 35
PDF
Payer Costs in Patients Undergoing Uterine Artery Embolization, Hysterectomy, or Myomectomy for Treatment of Uterine Fibroids
2007 · Carole J. Dembek, Elise M. Pelletier, et al. · Journal of Vascular and Interventional Radiology · 31
The cost offsets and cost–effectiveness associated with pegylated drugs: a review of the literature
2012 · Russell Becker, Carole Dembek, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 23
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain
2013 · Carole Dembek, Leigh Ann White, et al. · The European Journal of Health Economics · 20
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population
2021 · Aditi Kadakia, Brenna L. Brady, et al. · Journal of Medical Economics · 19
Effects of Cohort Selection on the Results of Cost-Effectiveness Analysis of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis
2011 · Russell V. Becker III, Carole Dembek · Journal of Managed Care Pharmacy · 19
PDF
The Economic Burden of Schizophrenia in the United States in 2019
2022 · Aditi Kadakia, Angela Fan, et al. · CNS Spectrums · 12
PDF
Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators
2019 · Allison Keshishian, Lin Xie, et al. · Clinical Therapeutics · 12
PDF
Payer Costs of Autologous Stem Cell Transplant: Results from a U.S. Claims Data Analysis
2008 · Elise M Pelletier, Paula J Smith, et al. · Blood · 12
Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
2020 · Maryam Navaie, Carole Dembek, et al. · Medicine · 11
Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
2018 · Krithika Rajagopalan, Lisa Bloudek, et al. · International Journal of COPD · 11
PDF
Observational Real-World Study to Assess Clinical Characteristics and Device Satisfaction in Patients with COPD Treated with Glycopyrrolate/eFlow® CS
2020 · Judith J Stephenson, Carole Dembek, et al. · International Journal of COPD · 9
PDF
Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies
2020 · Edward M Kerwin, Lindsey Murray, et al. · International Journal of COPD · 8
PDF
Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment
2019 · Bartolome R Celli, Maryam Navaie, et al. · International Journal of COPD · 8
PDF
Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US
2021 · Aditi Kadakia, Qi Fan, et al. · Current Medical Research and Opinion · 7
Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysis
2020 · Xiaoli Niu, Victoria Divino, et al. · Journal of Medical Economics · 7
A real-world data analysis of electronic health records to investigate the associations of predominant negative symptoms with healthcare resource utilisation, costs and treatment patterns among patients with schizophrenia
2024 · Rashmi Patel, Carole Dembek, et al. · BMJ Open · 6
Clinical Characterization of Nursing Facility Residents With Chronic Obstructive Pulmonary Disease
2021 · H. Edward Davidson, Peter Radlowski, et al. · The Senior Care Pharmacist · 6
The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis
2022 · Xiaoli Niu, Carole Dembek, et al. · Journal of Medical Economics · 5
Works count: 64
Citation count: 929
H-index: 12
I10-index: 17
Year
Topic
Type